Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99.

[1]  Xi-Lin Hou,et al.  Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria , 2007, Vaccine.

[2]  M. Sung,et al.  Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice , 2006, Journal of Virology.

[3]  Kevin F. Jones,et al.  Mucosal Vaccine Made from Live, Recombinant Lactococcus lactis Protects Mice against Pharyngeal Infection with Streptococcus pyogenes , 2004, Infection and Immunity.

[4]  P. Brandtzaeg.  Role of secretory antibodies in the defence against infections. , 2003, International journal of medical microbiology : IJMM.

[5]  J. Seegers.  Lactobacilli as live vaccine delivery vectors: progress and prospects. , 2002, Trends in biotechnology.

[6]  J. Holmgren,et al.  Recent advances in mucosal vaccines and adjuvants. , 2002, Current opinion in immunology.

[7]  A. Zuercher,et al.  Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. , 2002, Vaccine.

[8]  C. Locht,et al.  Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. , 2002, Vaccine.

[9]  M. Reitz,et al.  Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. , 2001, Vaccine.

[10]  M. Sung,et al.  Physiological and biochemical characteristics of poly γ-glutamate synthetase complex of Bacillus subtilis , 2001 .

[11]  D. Hone,et al.  Vaccination with a Shigella DNA Vaccine Vector Induces Antigen-Specific CD8+ T Cells and Antiviral Protective Immunity , 2001, Journal of Virology.

[12]  H. Müller-Alouf,et al.  Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with Recombinant Lactobacillus plantarum , 2000 .

[13]  C. Guzmán,et al.  Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. , 2001, Vaccine.

[14]  J. Lieberman,et al.  Induction of Human Immunodeficiency Virus (HIV)-Specific CD8 T-Cell Responses by Listeria monocytogenes and a Hyperattenuated Listeria Strain Engineered To Express HIV Antigens , 2000, Journal of Virology.

[15]  R. Leer,et al.  Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli , 2000, Immunology.

[16]  Chul-Joong Kim,et al.  Surface-displayed viral antigens on Salmonella carrier vaccine , 2000, Nature Biotechnology.

[17]  M. Isaka,et al.  Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant. , 1999, Vaccine.

[18]  W. Vos.  Gene expression systems for lactic acid bacteria. , 1999 .

[19]  M. Lasaro,et al.  Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli. , 1998, Immunology letters.

[20]  J. Wells,et al.  Oral vaccination of mice against tetanus with recombinant Lactococcus lactis , 1997, Nature Biotechnology.

[21]  R. Leer,et al.  The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. , 1996, Journal of biotechnology.

[22]  P. Brandtzaeg.  21 – Distribution and Characteristics of Mucosal Immunoglobulin-Producing Cells , 1994 .

[23]  P. Ogra.  Handbook of mucosal immunology , 1994 .

[24]  H. Moon,et al.  Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals , 1993, Vaccine.

[25]  M. Russell,et al.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit , 1993, Infection and immunity.

[26]  J. Mekalanos,et al.  Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium , 1992, Infection and immunity.

[27]  R Weltzin,et al.  New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection , 1991, Infection and immunity.

[28]  M. Kagnoff,et al.  Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. , 1987, Journal of immunology.

[29]  N. Dimmock,et al.  Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG , 1985, The Journal of experimental medicine.

[30]  D. Graham,et al.  Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. , 1984, Gastroenterology.

[31]  W. Gaastra,et al.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains. , 1982, Microbiological reviews.

[32]  B. Nagy.  Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis , 1980, Infection and immunity.

[33]  L. Babiuk,et al.  Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins , 1979, Infection and immunity.

[34]  Moon Hw.  Mechanisms in the pathogenesis of diarrhea: a review. , 1978 .

[35]  W. Jansen,et al.  Detection of the K99 antigen by means of agglutination and immunoelectrophoresis in Escherichia coli isolates from calves and its correlation with entertoxigenicity , 1976, Infection and immunity.